Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Payables (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Payables for 10 consecutive years, with $21.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Payables rose 105.66% to $21.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.3 million, a 105.66% increase, with the full-year FY2025 number at $21.3 million, up 105.66% from a year prior.
  • Payables was $21.3 million for Q4 2025 at Orthopediatrics, up from $8.5 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $22.6 million in Q3 2023 to a low of $8.5 million in Q3 2025.
  • A 5-year average of $14.0 million and a median of $12.7 million in 2023 define the central range for Payables.
  • Peak YoY movement for Payables: skyrocketed 107.58% in 2023, then tumbled 48.43% in 2024.
  • Orthopediatrics' Payables stood at $9.3 million in 2021, then rose by 19.57% to $11.2 million in 2022, then increased by 13.44% to $12.6 million in 2023, then fell by 18.27% to $10.3 million in 2024, then soared by 105.66% to $21.3 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Payables are $21.3 million (Q4 2025), $8.5 million (Q3 2025), and $12.7 million (Q2 2025).